Skip to content

Clinical trials

Phase 3 Melanoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 3 Country / region: Belgium Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20063
20081
20091
20101
20111
20124
20134
20141
20152
20161
20173
20182
20191
20213
20225
20235
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting10
Terminated7
Recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb13
European Organisation for Research and Treatment of Cancer - EORTC4
Hoffmann-La Roche4
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
GlaxoSmithKline2
Pfizer2
Regeneron Pharmaceuticals2
Amgen1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma44
Skin Neoplasms7
Neoplasm Metastasis6
Neoplasms3
Brain Neoplasms2
Nevus, Blue1
Skin Diseases1
Uveal Melanoma1

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.